The quantification and distinction of human intestine were considered
by an enzymatic approach, which comprised . the signal transduction fr
om receptor binding to cGMP formation, and, in addition, by showing th
e expression of an intracellular portion of these transmembrane protei
ns. Basal guanylyl cyclase (GC) activities were 50 to 80 pmol cGMP for
mation/min/mg protein and were stimulated up to twofold by heat stable
enterotoxin, but were not significantly influenced by atrial natriure
tic factor. Enzymatic analysis of colonoscopic specimens pointed to th
e prevalence of guanylyl cyclase C in the terminal ileum and in the la
rge bowel including colon ascendens, colon descendens, sigmoid, and re
ctum. The availability of sequence information on human guanylyl cycla
ses permitted the development of a polymerase chain reaction approach
for distinguishing the expression of GC-A and GC-C in human tissue sam
ples. The expression levels of particulate guanylyl cyclases found by
polymerase chain reaction in surgical biopsy specimens confirmed the e
nzymatic data, in that substantial expression of GC-C was found not on
ly in the small intestine but also in the large bowel. According to th
e restriction mapping of amplificates, GC-c prevailed over GC-A throug
hout the human intestine, particularly in the mucosal layers.